|
|
News Breaks
|
June 30, 2011
|
| 08:04 EDT |  | CORT |
| theflyonthewall.com: | FDA accepts submission of new Corcept drug application for CORLUX | | Corcept Therapeutics announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application, which was submitted on April 15, for CORLUX, a glucocorticoid receptor type II antagonist, for the treatment of the manifestations of Cushing's Syndrome. The FDA has indicated that this application will receive a standard review and that the Prescription Drug User Fee Act goal date for completion of its review is February 17, 2012. :theflyonthewall.com |
|
|
News For CORT From The Last 14 Days Check below for free stories on CORT the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 24, 2012
|
| 17:22 EDT |  | CORT |
|
|
|
|
|
Subscribe for More Information